MXMTX | NRGEX | MXMTX / NRGEX | |
Total Expense Ratio | 1.19 | 0.03 | 3,967% |
Annual Report Gross Expense Ratio | 1.71 | 0.69 | 248% |
Fund Existence | 10 years | 4 years | - |
Gain YTD | 3.237 | -3.342 | -97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 268M | 8.69B | 3% |
Annual Yield % from dividends | 0.79 | 0.54 | 147% |
Returns for 1 year | -5.17 | -9.46 | 55% |
Returns for 3 years | 23.59 | 8.17 | 289% |
Returns for 5 years | 1.40 | N/A | - |
Returns for 10 years | 41.52 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
HRLVX | 22.93 | 0.13 | +0.57% |
Harbor Large Cap Value Admin | |||
HADUX | 79.12 | 0.41 | +0.52% |
Horizon Equity Premium Income Advisor | |||
VLLIX | 49.30 | 0.06 | +0.12% |
Value Line Larger Companies Focus Instl | |||
CLBEX | 38.90 | 0.04 | +0.10% |
American Funds American Balanced 529E |